Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4562 ARTÍCULOS , VIENDO DEL 1651 AL 1665

When All Else Fails: The Use of Electroconvulsive Therapy for Conditions Other than Major Depressive Episode

Rosenquist PB, Youssef NA, Surya S, McCall WV.

Psychiatr Clin North Am. 2018 Sep;41(3):355-371. doi: 10.1016/j.psc.2018.04.002. Epub 2018 Jun 15.

Rotigotine transdermal patch for the treatment of neuropsychiatric symptoms in Parkinson's disease: A meta-analysis of randomized placebo-controlled trials

Wang HT, Wang L, He Y, Yu G.

J Neurol Sci. 2018 Oct 15;393:31-38. doi: 10.1016/j.jns.2018.08.003. Epub 2018 Aug 3.

Sleep in Parkinson's Disease with Impulse Control Disorder

Figorilli M, Congiu P, Lecca R, Gioi G, Frau R, Puligheddu M.

Curr Neurol Neurosci Rep. 2018 Aug 11;18(10):68. doi: 10.1007/s11910-018-0875-x.

Degenerative or Debilitative Neurologic Syndromes

Parish AL.

Nurs Clin North Am. 2018 Sep;53(3):447-457. doi: 10.1016/j.cnur.2018.05.002.

Mendel and urate: Acid test or random noise?

Brown EG, Goldman SM, Tanner CM.

Parkinsonism Relat Disord. 2018 Aug;53:1-3. doi: 10.1016/j.parkreldis.2018.08.005. Epub 2018 Aug 7.

Decreasing subthalamic deep brain stimulation frequency reverses cognitive interference during gait initiation in Parkinson's disease

Varriale P, Collomb-Clerc A, Van Hamme A, Perrochon A, Kemoun G, Sorrentino G, George N, Lau B, Karachi C, Welter ML.

Clin Neurophysiol. 2018 Nov;129(11):2482-2491. doi: 10.1016/j.clinph.2018.07.013. Epub 2018 Aug 2.

Fast, Broad, and Irregular: Wolff-Parkinson-White Syndrome

Makhija RR, Chow T, Venugopal S, Amsterdam EA.

Am J Med. 2018 Dec;131(12):1456-1459. doi: 10.1016/j.amjmed.2018.07.038. Epub 2018 Aug 11.

Zonisamide cotreatment delays striatal dopamine transporter reduction in Parkinson disease: A retrospective, observational cohort study

Ikeda K, Yanagihashi M, Miura K, Ishikawa Y, Hirayama T, Takazawa T, Kano O, Kawabe K, Mizumura N, Iwasaki Y.

J Neurol Sci. 2018 Aug 15;391:5-9. doi: 10.1016/j.jns.2018.05.013. Epub 2018 May 17.

A new scale measuring adaptive perceived control for people with Parkinson's: Initial construction and further validation

Simpson J, Chatzidamianos G, Fletcher I, Perpetuo L, Eccles FJR.

J Neurol Sci. 2018 Aug 15;391:77-83. doi: 10.1016/j.jns.2018.05.023. Epub 2018 Jun 2.

Sex: A Significant Risk Factor for Neurodevelopmental and Neurodegenerative Disorders

Pinares-Garcia P, Stratikopoulos M, Zagato A, Loke H, Lee J.

Brain Sci. 2018 Aug 13;8(8):154. doi: 10.3390/brainsci8080154.

Levodopa-Carbidopa Intestinal Gel in Parkinson's Disease: A Systematic Review and Meta-Analysis

Wang L, Li J, Chen J.

Front Neurol. 2018 Jul 30;9:620. doi: 10.3389/fneur.2018.00620. eCollection 2018.

Author response: Pimavanserin: A novel therapeutic option for Parkinson disease psychosis

Berman BD, Hawkins T.

Neurol Clin Pract. 2018 Jun;8(3):175-176. doi: 10.1212/CPJ.0000000000000470.

Reader response: Pimavanserin: A novel therapeutic option for Parkinson disease psychosis

Keys Lawler AC, Torres-Yaghi Y, Amjad F, Moussa C, Pagan F.

Neurol Clin Pract. 2018 Jun;8(3):175. doi: 10.1212/CPJ.0000000000000467.

Camptocormia: Etiology, diagnosis, and treatment response

Ali F, Matsumoto JY, Hassan A.

Neurol Clin Pract. 2018 Jun;8(3):240-248. doi: 10.1212/CPJ.0000000000000453.

Targeting the noradrenergic system for anti-inflammatory and neuroprotective effects: implications for Parkinson's disease

O'Neill E, Harkin A.

Neural Regen Res. 2018 Aug;13(8):1332-1337. doi: 10.4103/1673-5374.235219.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias